Brief: Edgewise Therapeutics Announces Initiation Of Grand Canyon, A Global Pivotal Study Of Edg-5506 In Becker Muscular Dystrophy
26/09/2023 13:09
Sept 26 (Reuters) - Edgewise Therapeutics Inc EWTX.O :
* EDGEWISE THERAPEUTICS INC - ANNOUNCES INITIATION OF GRAND
CANYON, A GLOBAL PIVOTAL STUDY OF EDG-5506 IN BECKER MUSCULAR
DYSTROPHY
Source text for Eikon: ID:nBw6PCT7La
Further company coverage: EWTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Edgewise Therapeutics
See all newsBrief: Edgewise Therapeutics Doses First Patient In Phase 2 Equinox-Hfpef Trial Of Edg-15400
Edgewise Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Edgewise Therapeutics Q2 net loss widens on higher expenses
Brief: Edgewise Therapeutics Q2 Operating Income USD -61.943 Million
U.S. STOCKS ON THE MOVE-RBB Bancorp, Roblox, Open Lending